TORONTO Lockdowns have been initiated in the United Kingdom, as Canada as well as several European Union countries cancel flights after information was revealed about a new variant of the virus that causes COVID-19. Researchers are rigorously examining how the mutations arose, what it means for vaccines, and updating their understanding of the virus.
In a tweet, Prime Minister Justin Trudeau announced Sunday evening that Canada would be restricting flights from the U.K. for at least 72 hours. This afternoon, I convened a meeting with the Incident Response Group. We focused on the new variant of COVID-19 identified in the UK, and we have decided to implement new border restrictions in order to keep you - and people right across the country - safe, the prime minister wrote on Twitter.
Covid 19 coronavirus: Scientists alarmed at spread of Covid mutant
20 Dec, 2020 06:28 PM
4 minutes to read
Financial Times
By: Clive Cookson
New strain of virus is 70 per cent more transmissible but seemingly no more deadly after its detection in UK and elsewhere. The highly infectious variant of coronavirus that has emerged in south-east England is spreading rapidly to the rest of the UK and is already present elsewhere in the world, scientists warned on Sunday.
The World Health Organisation said its Evolution Working Group is working closely with the UK medical authorities to understand how the variant, now called B.1.1.7, is likely to affect the course of the pandemic. It has been detected in the Netherlands, Denmark and Australia.
In Vitro Diagnostic (IVD) Test Market 2020 - Global Industry Analysis, By Key Players, Segmentation, Trends and Forecast By 2026 newyorktelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newyorktelegraph.com Daily Mail and Mail on Sunday newspapers.
Ambry Genetics Named Best Company for Women and Workplace Culture
Comparably Ranks Ambry a Top Employer Out of 60,000 Companies Based on Employee High Ratings
News provided by
Share this article
ALISO VIEJO, Calif., Dec. 17, 2020 /PRNewswire/
Ambry Genetics Corporation (Ambry), a leading clinical diagnostic testing company, is proud to announce that they are the recipient of two Comparably Awards in recognition of the best companies for women and for providing an outstanding workplace culture.
Comparably is a leading workplace culture site with a mission to make workplaces more transparent and rewarding. Its rankings reflect anonymous employee sentiment ratings based on work environment, culture, work-life balance, leadership, workplace opportunities, and benefits as well as how proud employees feel about their company.
News Category Global Banking & Finance Reviews
Rhythm Pharmaceuticals Announces Appointments of Camille L. Bedrosian, M.D., and Lynn Tetrault, J.D., to its Board of Directors
Rhythm Pharmaceuticals Announces Appointments of Camille L. Bedrosian, M.D., and Lynn Tetrault, J.D., to its Board of Directors
BOSTON, Dec. 11, 2020 Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity, today announced the appointments of Camille L. Bedrosian, M.D., and Lynn Tetrault, J.D., to its Board of Directors.
“I am thrilled to welcome both Camille and Lynn to our Board of Directors, as both leaders have tremendous experience building and leading teams that work effectively to bring new medicines to patients in need,” said David Meeker, M.D., Chair, President and Chief Executive Officer of Rhythm.